Beyfortus-nirsevimab injection (Drug Label Information)

• 2024

  Log in to bookmark this resource.

  Log in

---

Access Resources

• Job AidEN
• Ask aRCie About This Resource

About

This webpage provides drug label information for the Beyfortus- nirsevimab injection. It describes the drug's dosage, forms, and strengths. Beyfortus is given as an injection and comes in pre-filled syringes of 50 mg/0.5 mL or 100 mg/mL. It also provides links to further information on safety and related resources.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Anaphylaxis; Drug Hypersensitivity; Immunoglobulin G; Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Antibodies, Monoclonal, Humanized

Institutions: National Library of Medicine

---

More like this

Curriculum Recommendations for Disaster Health Professionals: Disaster Behavioral Health (2nd ed.) 2020 · National Center for Disaster Medicine and Public Health (NCDMPH), Uniformed Services University Nirsevimab None · National Institutes of Health (NIH) Pediatric Pandemic Network Disaster Cycle 2025 · Pediatric Pandemic Network (PPN)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---